Medical Management of Chronic Subdural Hematoma

Kyung Hwan Kim; Young Lee

doi:10.13004/kjnt.2023.19.e47

Medical Management of Chronic Subdural Hematoma

Korean J Neurotrauma. 2023 Sep 19;19(3):288-297. doi: 10.13004/kjnt.2023.19.e47. eCollection 2023 Sep.

Authors

Kyung Hwan Kim¹, Young Lee¹

Affiliation

¹ Department of Neurosurgery, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.

Abstract

Chronic subdural hematoma (CSDH) is a commonly encountered disease in the field of neurosurgery, typically resulting from head trauma. Several medical treatments have been introduced to manage patients with CSDH though surgical drainage is the main strategy to manage symptomatic patients. This review is aimed to meticulously examine contemporary pharmacological approaches, based on a thorough understanding of CSDH pathophysiology. Finally, the review offers a glance into future perspectives to enhance the management of CSDH.

Keywords: ACE inhibitor; Chronic subdural hematoma; Corticosteroid; Statin; Tranexamic acid.

Publication types

Review